The strongest prognostic factor for all glioma histologies is mutation in one of the isocitrate dehydrogenase genes (IDH1 or IDH2) [48], and mutation of these genes is seen at higher frequencies in lower grade gliomas and secondary GBMs. This evidence concerns the gene IDH2 and central nervous system cancer.